Literature DB >> 8107060

A mechanism of pathogenicity of "Streptococcus milleri group" in pulmonary infection: synergy with an anaerobe.

T Shinzato1, A Saito.   

Abstract

The relationship between Streptococcus constellatus, one of the species of the "Streptococcus milleri group", and Prevotella intermedia was studied in a model of pneumonia in mice and in vitro to elucidate mechanisms of pathogenicity in "S. milleri group"-associated pulmonary infection. Acute pneumonia with or without empyema and lung abscess in mice with mixed infection resulted in 60% mortality rate, but there was only 10% mortality and mild pneumonia in each separate infection. Bacterial clearance of organisms, especially S. constellatus, in mixed infection was delayed. Enhancement of growth of S. constellatus was demonstrated when cultured with P. intermedia; growth was also stimulated by a culture filtrate of P. intermedia which also inhibited bactericidal activity of human neutrophils. In an examination of infectivity and bacterial clearance of S. constellatus with P. intermedia culture filtrate in vivo, there was 20% mortality and delayed clearance of S. constellatus, although the infection was not as severe as that produced by the combination of both organisms. These results suggest that P. intermedia may act with S. constellatus in the production of pulmonary infections by stimulating its growth and suppressing bactericidal activity of the host.

Entities:  

Mesh:

Year:  1994        PMID: 8107060     DOI: 10.1099/00222615-40-2-118

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  14 in total

Review 1.  Systemic diseases caused by oral infection.

Authors:  X Li; K M Kolltveit; L Tronstad; I Olsen
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  BTS guidelines for the management of pleural infection.

Authors:  C W H Davies; F V Gleeson; R J O Davies
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

3.  In vitro effects of N-acetyl cysteine alone and in combination with antibiotics on Prevotella intermedia.

Authors:  Ji-Hoi Moon; Eun-Young Jang; Kyu Sang Shim; Jin-Yong Lee
Journal:  J Microbiol       Date:  2015-05-03       Impact factor: 3.422

4.  Precipitating factors in the pathogenesis of peritonsillar abscess and bacteriological significance of the Streptococcus milleri group.

Authors:  H Hidaka; S Kuriyama; H Yano; I Tsuji; T Kobayashi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-11-18       Impact factor: 3.267

5.  Pyrosequencing reveals the complex polymicrobial nature of invasive pyogenic infections: microbial constituents of empyema, liver abscess, and intracerebral abscess.

Authors:  C D Sibley; D L Church; M G Surette; S E Dowd; M D Parkins
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-28       Impact factor: 3.267

6.  Characterization of Streptococcus milleri group isolates from expectorated sputum of adult patients with cystic fibrosis.

Authors:  Margot E Grinwis; Christopher D Sibley; Michael D Parkins; Christina S Eshaghurshan; Harvey R Rabin; Michael G Surette
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

7.  In Vitro Effects of Polyphosphate against Prevotella intermedia in Planktonic Phase and Biofilm.

Authors:  Eun-Young Jang; Minjung Kim; Mi Hee Noh; Ji-Hoi Moon; Jin-Yong Lee
Journal:  Antimicrob Agents Chemother       Date:  2015-11-23       Impact factor: 5.191

8.  Prevotella intermedia induces severe bacteremic pneumococcal pneumonia in mice with upregulated platelet-activating factor receptor expression.

Authors:  Kentaro Nagaoka; Katsunori Yanagihara; Yoshitomo Morinaga; Shigeki Nakamura; Tatsuhiko Harada; Hiroo Hasegawa; Koichi Izumikawa; Yuji Ishimatsu; Hiroshi Kakeya; Masaharu Nishimura; Shigeru Kohno
Journal:  Infect Immun       Date:  2013-11-18       Impact factor: 3.441

Review 9.  A practical guide to the oral microbiome and its relation to health and disease.

Authors:  K Krishnan; T Chen; B J Paster
Journal:  Oral Dis       Date:  2016-07-04       Impact factor: 3.511

10.  Streptococcus milleri pulmonary disease: a review and clinical description of 25 patients.

Authors:  C A Wong; F Donald; J T Macfarlane
Journal:  Thorax       Date:  1995-10       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.